STADAPHARM

STADAPHARM is the specialty pharmaceuticals division of the STADA Group, a leading global manufacturer of generic and over-the-counter drugs. Based in Bad Vilbel, Germany, the company focuses on high-growth segments including biosimilars and specialty therapies for complex conditions such as Parkinson's disease, oncology, and nephrology. STADAPHARM manages a diverse portfolio that includes both proprietary brands and partnered products, emphasizing affordable access to critical medicines. The company plays a pivotal role in STADA's 'Three-Pillar Strategy,' which balances generics, specialty products, and consumer healthcare. Through strategic partnerships and a robust pipeline of biosimilars, STADAPHARM continues to expand its footprint in the European healthcare market.